A federal judge has ruled that the Trump administration cannot bar HIV clinics that receive federal money from acknowledging transgender patients or giving them gender-affirming care. The policies are “based in animus, loathing, and discrimination,” U.S. District Judge William Young wrote on Thursday in a 165-page decision.
The money at stake runs through the Ryan White HIV/AIDS Program, which Congress created in 1990 to pay for medical care for low-income and uninsured people with HIV. Black Americans are 12% of the U.S. population and were 39% of new HIV diagnoses in 2022, according to KFF’s analysis of federal data. They are 40% of the people living with the virus. When a rule threatens the clinics that program pays for, it threatens Black patients first by sheer numbers.
Beginning in March, the Health Resources and Services Administration, the HHS agency that runs the program, added funding conditions to carry out Trump’s executive order recognizing only two sexes. Providers were told to use “sex-based definitions grounded in biological reality” and to avoid “social or medical experimentation.” Medical groups, including the American Academy of HIV Medicine, sued in June. They argued the conditions conflict with the law’s mandate to provide comprehensive medical care, which has historically included hormone therapy for transgender patients, and that they burden doctors’ free speech.
Young heard the case at a bench trial in September. The administration rejected a settlement proposal in October, so clinics were left facing a choice no medical provider should face: keep federal money or keep treating the patient in front of them. Lambda Legal, which represents plaintiffs, argued that for transgender people with HIV, “being respected by a provider is not incidental to care; it is part of what makes care accessible and effective.”
That is also a public health point, not only a civil rights one. HIV treatment works only when people stay in care. Among Black people with HIV, 64% were linked to care in 2022 and 53% had a suppressed viral load, against 70% and 63% for white people, KFF reports. Those gaps trace to stigma, poverty and lack of access, and a policy that tells patients their clinic may not see them as they are adds one more reason to stay away.
The administration can appeal. Until it does, and until a higher court says otherwise, the ruling means clinics can keep both their funding and their patients. The government had a settlement on the table in front of it and chose a trial instead. It lost, and the judge’s words about why will be in the record when it asks a higher court for a second try.


Have your say